drug-injecting microneedles
Scope
Date
~
-
Bio & Pharma
Yuhan’s lung cancer drug clears FDA hurdle for global debut
A new lung cancer treatment developed by South Korea’s Yuhan Corp. has secured approval from the US Food and Drug Administration (FDA) as a co...
Aug 21, 2024 (Gmt+09:00)
-
Bio & Pharma
IMBiologics transfers autoimmune disease drug tech to Huadong Pharma
South Korea's antibody-based biotech company IMBiologics announced on Friday that it signed a contract to transfer the technology of its autoimmune ...
Aug 16, 2024 (Gmt+09:00)
-
Bio & Pharma
Costco sells Celltrion's Yuflyma Low WAC in US
South Korea's Celltrion Inc. announced on Tuesday that its autoimmune disease treatment Yuflyma (Low WAC, active ingredient adalimumab) is now avail...
Aug 13, 2024 (Gmt+09:00)
-
Carbon neutrality
SK Earthon wins Australian carbon storage exploration rights
SK Earthon Co., the energy resources exploration and production (E&P) unit of South Korea’s top energy company SK Innovation Co., will spe...
Aug 08, 2024 (Gmt+09:00)
-
Steel
SIMPAC, Brazil's RIMA to set up ferrosilicon joint venture
SIMPAC Inc., a South Korean ferroalloy producer, said on Monday that it will establish a joint venture with Brazilian silicon alloy manufacturer RIM...
Aug 06, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Zymfentra joins US insurance-covered drug lists
South Korean biosimilar maker Celltrion Inc. said on Monday that its subcutaneous injection formulation for autoimmune diseases, Zymfentra (inflixim...
Aug 06, 2024 (Gmt+09:00)
-
Bio & Pharma
Huonslab eyes speedy anticancer drug delivery with new patent
South Korean biotech Huons Global Co. said on Tuesday that its research and development unit Huonslab has issued a domestic patent claiming a techno...
Jul 23, 2024 (Gmt+09:00)
-
Corporate strategy
POSCO seeks restructuring for $1.9 bn injection in battery materials
POSCO Holdings Inc. aims to raise its corporate value through an ambitious scheme that entails securing 2.6 trillion won ($1.9 billion) through rest...
Jul 14, 2024 (Gmt+09:00)
-
Korean chipmakers
Korea to inject $200 mn into semiconductor packaging R&D
South Korea will inject 274.4 billion won ($200 million) into a state-run R&D project for semiconductor packaging technology, a key to producing...
Jun 26, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm mulls acquiring firms, drug sales rights in US
SAN DIEGO, California -- South Korea’s SK Biopharmaceuticals Co. is considering acquiring firms in the US, or the sales rights to some of thei...
Jun 07, 2024 (Gmt+09:00)
-
Bio & Pharma
Handok gets Biocon's obesity drug exclusive distribution in S.Korea
South Korean pharmaceutical company Handok Inc. announced on Friday that it signed an exclusive domestic sales and distribution agreement with India...
May 24, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion eyes M&A in Europe, $3.3 bn Zymfentra sales: chairman
WASHINGTON, D.C. – South Korean biosimilar giant Celltrion Inc. is accelerating its push to transform into a novel drug developer, going after...
May 23, 2024 (Gmt+09:00)
-
Bio & Pharma
S.Korean anti-obesity drugmakers eye niche demand
The global weight management market has entered a new chapter following the arrival of blockbuster weight-loss medication Wegovy, and South Korean l...
May 07, 2024 (Gmt+09:00)
-
Banking & Finance
S.Korea’s Lotte Card injects $68 mn into Vietnamese unit
Lotte Card Co., South Korea’s No. 5 credit card issuer, has injected $68 million into its Vietnamese unit to expand its business in the Southe...
May 02, 2024 (Gmt+09:00)
-
Bio & Pharma
HK inno.N to release K-CAB in MENA market
South Korean bio-health company HK inno.N announced on Tuesday that it signed a contract with Saudi Arabian local pharmaceutical company Tabuk Pharm...
Apr 23, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Blackstone signs over $1 bn deal with MBK for 1st exit in Korea
Private equity giant Blackstone Inc. is set to mark its first exit from South Korea by selling a 71.25% stake in the holding firm of Geo-Young Corp....
Apr 22, 2024 (Gmt+09:00)
-
Corporate strategy
Samsung shifts to emergency mode with 6-day work week for executives
Executives at all Samsung Group units will work six days a week from as early as this week in a shift to emergency mode. The move comes as the won's...
Apr 18, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung begins new drug development for rare diseases
Samsung Bioepis Co., a biosimilar development unit of South Korea’s top conglomerate Samsung Group, has begun its new drug development busines...
Mar 24, 2024 (Gmt+09:00)
-
Earnings
Samsung Electronics collects $4.3 bn in dividends from display unit
Samsung Electronics Co., the world’s largest memory chipmaker, is slated to receive about 5.64 trillion won ($4.3 billion) worth of dividends ...
Mar 21, 2024 (Gmt+09:00)
-
Corporate investment
LG injects $97 mn into Vista Equity’s fund for new tech investments
LG Group, South Korea’s fourth-largest conglomerate, injected $97 million into a fund run by Vista Equity Partners Management LLC for investme...
Mar 20, 2024 (Gmt+09:00)
-
Bio & Pharma
Drug maker Boryung targets its highest-ever sales in 2024
Boryung Corp., formerly Boryung Pharmaceutical Co., aims to join the 1 trillion won ($748 million) sales club this year, driven by new chronic disea...
Mar 20, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion'a autoimmune disease drug Zymfentra makes US debut
South Korean biopharmaceutical giant Celltrion Inc. said on March 17 that it has launched its new autoimmune disease treatment Zymfentra in the US m...
Mar 18, 2024 (Gmt+09:00)
-
Economy
Korea eyes $1.5 bn injection in KDB to boost chip, battery sectors
South Korea may inject some 2 trillion won ($1.5 billion) into Korea Development Bank (KDB) by the end of this month to support the state-run bank's...
Mar 18, 2024 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharmaceutical digitizes DB of 800 mn chemical compounds
South Korea's Daewoong Pharmaceutical announced on Monday that it has established a drug development system Daewoong AI System (DAISY) which combine...
Feb 19, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm targets $311 mn for Cenobamate US sales
South Korea's SK Biopharmaceuticals targeted 416 billion won ($311 million) for its epilepsy treatment Cenobamate in the US market this year. SK Bi...
Feb 16, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion, WuXi XDC to develop new antibody-drug conjugates
South Korea’s Celltrion Inc. has signed a business agreement with China’s WuXi XDC to jointly develop new antibody-drug conjugates (ADC)...
Jan 24, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to export three anticancer drugs to Europe
South Korea’s Celltrion Inc. announced on Thursday that it has secured supply contracts for three anticancer biosimilars in European countries...
Jan 18, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem to start phase 3 for head, neck cancer drug in US
South Korea’s LG Chem Ltd. announced on Wednesday that its US-based subsidiary Aveo Pharmaceuticals will start Phase 3 clinical trials for its...
Jan 17, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Orion to buy control of biotech startup LegoChem for $415 mn
South Korea’s snack and confectionery maker Orion Group has agreed to buy a controlling stake in LegoChem Biosciences Inc., a Korean biotech s...
Jan 15, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
OCI-Hanmi merger to create Korea’s Bayer: OCI Chairman
Merging into one team, OCI Group and Hanmi Pharmaceutical Group will leap forward to be a global novel drug manufacturing and biotechnology innova...
Jan 15, 2024 (Gmt+09:00)
Latest News
- 1 Hyundai, Kia’s H1 vehicle sales in Singapore double, aided by HMGICS
- 2 Korea’s reshoring companies pale amid lack of support, incentives, tax breaks
- 3 Hyundai, Waymo forge multi-year, strategic partnership for self-driving vehicles
- 4 AI startup MarqVision raises $16.5 mn to close Series A
- 5 Taihan Cable wins $630 mn power grid project in Singapore